Bausch Health Companies (BHC) Other Non Operating Income (2009 - 2026)
Bausch Health Companies (BHC) posted Other Non Operating Income of -$7.0 million for Q2 2026, up 36.36% sequentially from -$11.0 million in Q1 2026, and down 103.93% YoY from $178.0 million in Q2 2025.
Bausch Health Companies (BHC) Other Non Operating Income (2009 - 2026) Analysis & Trends
Bausch Health Companies has reported Other Non Operating Income for 18 years, with the latest figure at -$7.0 million in Q2 2026.
- Quarterly Other Non Operating Income fell 103.93% year-over-year to -$7.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$44.0 million (down 128.76% YoY) and the FY2025 annual result came in at $162.0 million, up 444.68% from the prior year.
- Other Non Operating Income rose to -$7.0 million in Q2 2026 per BHC's latest filing, from -$11.0 million in the prior quarter.
- Over five years, Other Non Operating Income peaked at $570.0 million in Q3 2022 and troughed at -$21.0 million in Q2 2023.
- A 5-year average of $65.5 million and a median of -$7.0 million in 2022 frame the typical range for Other Non Operating Income.
- The sharpest annual moves came in 2022 and 2024: Other Non Operating Income surged 4850.0% in 2022, then plunged 2200.0% in 2024.
- Over 5 years, Other Non Operating Income stood at $369.0 million in 2022, then sank by 99.73% to $1.0 million in 2023, then slumped by 2200.0% to -$21.0 million in 2024, then climbed by 9.52% to -$19.0 million in 2025, then soared by 63.16% to -$7.0 million in 2026.
- According to Business Quant data, Other Non Operating Income over the past three periods registered -$7.0 million, -$11.0 million, and -$19.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.33 Bn | 2.15 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.15 Bn | 19.48 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - |
| 10 | Bausch Health Companies | 2.57 Bn | 728.87 Mn | 2.10 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -7.00 Mn |
| Mar 31, 2026 | -11.00 Mn |
| Dec 31, 2025 | -11.00 Mn |
| Sep 30, 2025 | -7.00 Mn |
| Jun 30, 2025 | -30.00 Mn |
| Dec 31, 2024 | 49.00 Mn |
| Jun 30, 2024 | -11.00 Mn |
| Mar 31, 2024 | -15.00 Mn |
| Dec 31, 2023 | 1.00 Mn |
| Sep 30, 2023 | -7.00 Mn |
| Jun 30, 2023 | 10.00 Mn |
| Mar 31, 2023 | -10.00 Mn |
| Dec 31, 2022 | 369.00 Mn |
| Sep 30, 2022 | 570.00 Mn |
| Jun 30, 2022 | 113.00 Mn |
| Mar 31, 2022 | -7.00 Mn |
| Dec 31, 2021 | -4.00 Mn |
| Sep 30, 2021 | -12.00 Mn |
| Jun 30, 2021 | 7.00 Mn |
| Mar 31, 2021 | 1.00 Mn |